Dublin-based and London Stock Exchange-listed UDG Healthcare has announced a $32m deal to buy US healthcare group Vynamic.
The Philadelphia company specialises in brand strategy and the planning and launch of new drugs and healthcare products.
The acquisition of Vynamic is in line with the strategy of UDG's Ashfield business to expand its advisory services to the healthcare industry. It follows the acquisition of the STEM business last October.
The company said the deal is its first management consultancy acquisition and offers services which are highly complementary to the existing range of services provided by Ashfield.
"Vynamic is an excellent fit for UDG Healthcare, both strategically and culturally, and demonstrates our strategic commitment to developing our market leading positions through geographic and services expansion," UDG's chief executive Brendan McAtamney said.
UDG Healthcare also said today that it had secured competition approval for the acquisition of Sellxpert, a German contract sales outsourcing business for a total potential consideration of up to $14.4m.
The deal was first announced in May.